Nicotinic receptors as targets for therapeutic discovery
- 29 August 2007
- journal article
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 2 (9) , 1185-1203
- https://doi.org/10.1517/17460441.2.9.1185
Abstract
(2007). Nicotinic receptors as targets for therapeutic discovery. Expert Opinion on Drug Discovery: Vol. 2, No. 9, pp. 1185-1203. doi: 10.1517/17460441.2.9.1185Keywords
This publication has 172 references indexed in Scilit:
- Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitationNeurobiology of Disease, 2006
- Widespread decrease of nicotinic acetylcholine receptors in Parkinson's diseaseAnnals of Neurology, 2005
- Characterization of the human nicotinic acetylcholine receptor subunit alpha (α) 9 (CHRNA9) and alpha (α) 10 (CHRNA10) in lymphocytesLife Sciences, 2004
- Desensitized nicotinic receptors in brainPublished by Elsevier ,2004
- Nicotinic mechanisms of memory: effects of acute local DHβE and MLA infusions in the basolateral amygdalaCognitive Brain Research, 2003
- Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammationNature, 2002
- Smoking and mental illnessPharmacology Biochemistry and Behavior, 2001
- Ventral hippocampal α7 nicotinic receptor blockade and chronic nicotine effects on memory performance in the radial-arm mazePharmacology Biochemistry and Behavior, 2001
- (S)-(−)-5-Ethynyl-3-(1-methyl-2-pyrroli- dinyl)pyridine Maleate (SIB-1508Y): A Novel Anti-Parkinsonian Agent with Selectivity for Neuronal Nicotinic Acetylcholine ReceptorsJournal of Medicinal Chemistry, 1996
- Nicotine receptor mappingEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996